Safety and tolerability of AZD5148 in Japanese participants

Trial Identifier:	D8820C00005
Sponsor:	AstraZeneca
Start Date:	October 2024
Primary Completion Date:	January 2026
Study Completion Date:	January 2026

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
JP	Sumida-ku, JP, 130-0004

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.